Two things happened to Rocket Lab in the same week. On June 22, RKLB officially joined the Nasdaq-100 Index, putting it inside the major Nasdaq-100–tracking ETFs and index products. And earlier this month, SpaceX debuted on the Nasdaq, valued at roughly $2 trillion, instantly becoming one of the largest companies on earth.
That combination is why the stock sold off on inclusion day. And why it’s still the most interesting space story in public markets right now.
Analyst Targets
- KeyBanc: Upgraded to Overweight, $135 price target (June 15)
- Clear Street: Buy, raised target to $129 from $98 (June 3)
- Street consensus: ~$105-$107 average; analyst range of $47 to $150
The Business Right Now
Rocket Lab reported Q1 2026 revenue of $200.3 million, a 63.5% year-over-year increase. That number beat management guidance on revenue, gross margin, and adjusted EBITDA. The company guided Q2 2026 revenue to $225-$240 million, suggesting the growth rate is holding.
The backlog is the number that matters most: $2.2 billion as of Q1, up 108% from the prior year. That’s locked-in future revenue. Not projections. Contracts.
- Q1 2026 revenue: $200.3 million (+63.5% YoY)
- Q2 2026 revenue guidance: $225 million to $240 million
- Contract backlog: $2.2 billion (+108% YoY)
- Total launch manifest: 70+ contracted missions
- 52-week range: $31.78 to $151.00
- Current price (June 24): approximately $85-$95
Why the Defense Story Is Bigger Than People Realize
The part people skip: Rocket Lab isn’t primarily a launch company anymore. Its Space Systems segment now accounts for roughly two-thirds of revenue. And its defense contract portfolio is substantial. The company’s portfolio includes an $816 million Space Development Agency Tracking Layer Tranche 3 satellite award, a $190 million HASTE hypersonic contract covering 20 launches, a $90 million GEO surveillance award to build and operate two GEO satellites hosting the Heimdall space domain awareness payload, and a $24.35 million Neutron upper-stage development award.
It also completed the acquisition of Mynaric, adding space-based laser communications to its portfolio, and was selected alongside Raytheon to demonstrate capabilities for the U.S. Space Force’s Space Based Interceptor program. This is not a small satellite company anymore.
What’s interesting is that all of this happened with almost no attention. The SpaceX IPO sucked all the oxygen out of the space sector news cycle, and RKLB slid while its fundamentals kept improving.
The SpaceX Dynamic
Here’s where it gets complicated. Before SpaceX went public, Rocket Lab was a primary way institutional investors got pure-play space exposure. That scarcity premium was real. Now SpaceX is public at roughly $2 trillion, and investors who want the dominant space franchise can own it directly.
The question isn’t whether SpaceX is better. It clearly is, at scale. The question is whether the valuation gap between a $2 trillion company and Rocket Lab makes RKLB the more interesting risk-reward. On revenue multiples alone, RKLB trades at a fraction of SpaceX’s implied multiple, with faster near-term growth rates and a more concentrated catalyst calendar.
Bull / Base / Bear
Bull: Neutron successfully launches in Q4 2026, Rocket Lab becomes the only Western alternative to SpaceX for medium-lift payloads. Defense backlog continues expanding. Stock re-rates toward $130-$150. The Nasdaq-100 inclusion drives durable passive fund buying that supports the multiple.
Base: Neutron faces a 1-2 quarter delay, Space Systems and Electron continue growing on plan, defense contracts provide revenue stability. Stock consolidates in the $85-$110 range through year-end, re-rates on Neutron news.
Bear: Neutron maiden launch fails. Investors rotate into SpaceX directly. Index inclusion flows dissipate. Stock revisits low $70s. The company remains unprofitable and the timeline to profitability shifts right materially.
Technical Overlay
RKLB set a 52-week high of $151 on May 27, then sold off into the SpaceX IPO/June index-change window. It’s now hovering near the $85-$95 zone. Technical analysts are watching $95-$105 as the critical support range, where the 50-day moving average overlaps with post-Q1 breakout levels. A decisive close below $85 opens downside toward $75-$80. Confirmed reclaim above $100 strengthens the outlook heading into the Neutron launch window.
What Investors Should Watch
- Neutron development updates: any timeline shift (positive or negative) is a binary catalyst
- Defense contract pipeline: additional Space Force, SDA, or hypersonic awards would reinforce the thesis
- Passive fund flows: the Nasdaq-100 inclusion affects $1.4 trillion in total notional value across ETFs, mutual funds, and structured products
- SpaceX trading behavior: how institutional money allocates between the two names will determine whether RKLB’s premium survives
- Q2 earnings: expected to show further revenue growth with backlog conversion accelerating
Bottom Line
Rocket Lab earned its Nasdaq-100 seat. The fundamentals back it. Record revenue, record backlog, meaningful defense contracts, and a Neutron launch schedule that could change the competitive landscape for medium-lift entirely.
What changed is the benchmark. SpaceX went public in June, around the same period RKLB joined the index. From here, every RKLB trading day happens in direct comparison to a ~$2 trillion competitor. That’s not necessarily bad. It just means the scarcity premium that used to prop this stock needs to be replaced by execution. And Neutron is the execution test that determines whether it happens.
For informational purposes only.
